These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32956213)

  • 1. Peripheral vascular endothelial growth factor changes after transcranial magnetic stimulation in treatment-resistant depression.
    Fukuda AM; Hindley LE; Kang JWD; Tirrell E; Tyrka AR; Ayala A; Carpenter LL
    Neuroreport; 2020 Nov; 31(16):1121-1127. PubMed ID: 32956213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
    Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
    Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral activation therapy during transcranial magnetic stimulation for major depressive disorder.
    Russo GB; Tirrell E; Busch A; Carpenter LL
    J Affect Disord; 2018 Aug; 236():101-104. PubMed ID: 29723763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis.
    Lan MJ; Chhetry BT; Liston C; Mann JJ; Dubin M
    Brain Stimul; 2016; 9(4):577-83. PubMed ID: 27017072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of transcranial magnetic stimulation on anhedonia in treatment resistant major depressive disorder.
    Fukuda AM; Kang JWD; Gobin AP; Tirrell E; Kokdere F; Carpenter LL
    Brain Behav; 2021 Sep; 11(9):e2329. PubMed ID: 34453491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis.
    Rakesh G; Cordero P; Khanal R; Himelhoch SS; Rush CR
    J Affect Disord; 2024 Aug; 358():432-439. PubMed ID: 38740269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
    Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
    Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of 'cluster maintenance TMS' on irritability occurring in major depressive disorder.
    Pridmore S; Turnier-Shea Y; Erger S; May T
    Australas Psychiatry; 2021 Apr; 29(2):222-225. PubMed ID: 32722962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy.
    Minelli A; Maffioletti E; Bortolomasi M; Conca A; Zanardini R; Rillosi L; Abate M; Giacopuzzi M; Maina G; Gennarelli M; Bocchio-Chiavetto L
    Acta Psychiatr Scand; 2014 Jun; 129(6):461-6. PubMed ID: 23957507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
    Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
    J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.
    Hadas I; Sun Y; Lioumis P; Zomorrodi R; Jones B; Voineskos D; Downar J; Fitzgerald PB; Blumberger DM; Daskalakis ZJ
    JAMA Netw Open; 2019 Jun; 2(6):e195578. PubMed ID: 31167023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
    Janicak PG; Dunner DL; Aaronson ST; Carpenter LL; Boyadjis TA; Brock DG; Cook IA; Lanocha K; Solvason HB; Bonneh-Barkay D; Demitrack MA
    CNS Spectr; 2013 Dec; 18(6):322-32. PubMed ID: 23895940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
    Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
    Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression.
    Williams LM; Coman JT; Stetz PC; Walker NC; Kozel FA; George MS; Yoon J; Hack LM; Madore MR; Lim KO; Philip NS; Holtzheimer PE
    BMC Psychiatry; 2021 Jan; 21(1):35. PubMed ID: 33435926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
    Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
    World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression.
    Feffer K; Lapidus KAB; Braw Y; Bloch Y; Kron S; Netzer R; Nitzan U
    Eur Psychiatry; 2017 Jul; 44():61-67. PubMed ID: 28545010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of frontal cerebral blood volume during transcranial magnetic stimulation in depression is related to treatment effectiveness: A pilot study with near-infrared spectroscopy.
    Shinba T; Kariya N; Matsuda S; Matsuda H; Obara Y
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):602-610. PubMed ID: 29774621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.